Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E20.54 EPS (ttm)1.67 Insider Own0.05% Shs Outstand5.56B Perf Week1.12%
Market Cap192.02B Forward P/E11.16 EPS next Y3.06 Insider Trans-6.39% Shs Float5.55B Perf Month-2.26%
Income9.36B PEG3.05 EPS next Q0.79 Inst Own67.60% Short Float1.14% Perf Quarter-13.22%
Sales47.64B P/S4.03 EPS this Y-33.10% Inst Trans- Short Ratio1.57 Perf Half Y-2.15%
Book/sh11.71 P/B2.92 EPS next Y-7.21% ROA5.70% Target Price41.09 Perf Year-0.86%
Cash/sh2.18 P/C15.71 EPS next 5Y6.73% ROE14.90% 52W Range26.42 - 43.08 Perf YTD-7.09%
Dividend1.56 P/FCF51.74 EPS past 5Y2.20% ROI7.60% 52W High-20.61% Beta0.67
Dividend %4.56% Quick Ratio1.00 Sales past 5Y-3.00% Gross Margin79.10% 52W Low29.44% ATR0.61
Employees78500 Current Ratio1.40 Sales Q/Q11.80% Oper. Margin15.70% RSI (14)42.39 Volatility2.15% 1.42%
OptionableYes Debt/Eq0.63 EPS Q/Q125.10% Profit Margin20.20% Rel Volume1.13 Prev Close34.39
ShortableYes LT Debt/Eq0.59 EarningsFeb 02 BMO Payout87.90% Avg Volume40.09M Price34.20
Recom2.60 SMA20-0.54% SMA50-4.56% SMA200-3.36% Volume45,449,560 Change-0.55%
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Mar-05-21 05:16AM  
04:53AM  
02:12AM  
Mar-04-21 07:01PM  
05:45PM  
03:57PM  
02:44PM  
02:32PM  
02:06PM  
11:30AM  
11:09AM  
11:01AM  
10:17AM  
10:10AM  
10:00AM  
08:41AM  
08:22AM  
08:12AM  
07:27AM  
06:23AM  
06:12AM  
01:00AM  
Mar-03-21 07:03PM  
03:16PM  
03:02PM  
02:35PM  
02:18PM  
12:25PM  
12:05PM  
11:49AM  
10:47AM  
08:53AM  
08:46AM  
07:44AM  
07:13AM  
06:14AM  
05:47AM  
03:02AM  
02:33AM  
Mar-02-21 06:00PM  
03:51PM  
01:24PM  
12:12PM  
12:08PM  
11:51AM  
11:46AM  
10:58AM  
10:36AM  
10:32AM  
08:44AM  
08:18AM  
08:11AM  
07:59AM  
07:18AM  
07:00AM  
07:00AM  
06:58AM  
06:49AM  
06:05AM  
06:02AM  
04:35AM  
02:56AM  
Mar-01-21 11:15PM  
07:17PM  
05:14PM  
04:18PM  
04:16PM  
02:59PM  
01:56PM  
12:48PM  
12:45PM  
12:39PM  
11:07AM  
10:32AM  
10:27AM  
08:54AM  
08:38AM  
08:21AM  
07:56AM  
07:43AM  
07:15AM  
06:01AM  
06:00AM  
01:13AM  
Feb-28-21 04:57PM  
01:55PM  
09:37AM  
09:22AM  
06:01AM  
Feb-27-21 08:22PM  
06:39PM  
06:25PM  
06:19PM  
04:19PM  
02:34PM  
02:11PM  
08:17AM  
Feb-26-21 08:56PM  
07:24PM  
05:54PM  
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Verily Life Sciences LLC, Merck KGaA, Valneva SE, IDEAYA Biosciences, Inc., BioNTech SE, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, BioInvent International AB, Sosei Group Corporation, LianBio, and Imcyse S.A. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM
DAMICO JENNIFER B.SVP & ControllerApr 29Sale38.352,18183,6419,647May 01 03:56 PM
JOHNSON RADY AExecutive Vice PresidentApr 29Sale38.3613,125503,47563,940May 01 03:56 PM
ROGERS DAWNExecutive Vice PresidentApr 29Sale38.1313,000495,6904,823May 01 03:56 PM
LANKLER DOUGLAS MExecutive Vice PresidentApr 29Sale37.8565,0002,460,37278,276May 01 03:56 PM
PFIZER INC10% OwnerMar 16Buy16.00312,5005,000,0001,481,719Mar 16 07:15 PM